Tamarack Advisers as of Dec. 31, 2016
Portfolio Holdings for Tamarack Advisers
Tamarack Advisers holds 27 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 7.5 | $11M | 850k | 12.44 | |
| NxStage Medical | 6.8 | $9.6M | 368k | 26.21 | |
| Hologic (HOLX) | 6.5 | $9.2M | 230k | 40.12 | |
| Bio-Rad Laboratories (BIO) | 6.3 | $8.9M | 49k | 182.29 | |
| Pacira Pharmaceuticals (PCRX) | 6.2 | $8.8M | 273k | 32.30 | |
| Jazz Pharmaceuticals (JAZZ) | 5.9 | $8.4M | 77k | 109.03 | |
| Spectranetics Corporation | 5.7 | $8.1M | 330k | 24.50 | |
| Allscripts Healthcare Solutions (MDRX) | 5.5 | $7.8M | 765k | 10.21 | |
| Gilead Sciences (GILD) | 5.1 | $7.2M | 100k | 71.61 | |
| Teladoc (TDOC) | 4.8 | $6.9M | 416k | 16.50 | |
| Laboratory Corp. of America Holdings (LH) | 4.6 | $6.5M | 51k | 128.37 | |
| Novocure Ltd call | 4.6 | $6.5M | 825k | 7.85 | |
| Cardiome Pharma | 3.6 | $5.0M | 1.8M | 2.76 | |
| Obalon Therapeutics | 3.5 | $5.0M | 563k | 8.85 | |
| Amgen (AMGN) | 3.2 | $4.5M | 31k | 146.23 | |
| Alkermes (ALKS) | 3.1 | $4.3M | 78k | 55.58 | |
| athenahealth | 3.0 | $4.3M | 41k | 105.17 | |
| Steris Corporation | 3.0 | $4.2M | 63k | 67.40 | |
| Service Corporation International (SCI) | 2.5 | $3.6M | 125k | 28.40 | |
| Impax Laboratories | 2.4 | $3.4M | 258k | 13.25 | |
| Corium Intl | 2.1 | $3.0M | 737k | 4.06 | |
| Luminex Corporation | 1.9 | $2.7M | 135k | 20.23 | |
| Streamline Health Solutions (STRM) | 1.0 | $1.4M | 1.1M | 1.25 | |
| Boston Scientific Corporation (BSX) | 0.5 | $635k | 2.2k | 288.64 | |
| Quotient | 0.3 | $484k | 100k | 4.84 | |
| Henry Schein (HSIC) | 0.1 | $164k | 360.00 | 455.56 | |
| Stryker Corporation (SYK) | 0.0 | $27k | 250.00 | 108.00 |
